13G Filing: Scopia Capital and GW Pharmaceuticals PLC- ADR (GWPH)

Page 11 of 12

Page 11 of 12 – SEC Filing

SIGNATURE

After reasonable inquiry and to the best
of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

September 11, 2017
(Date)
SCOPIA CAPITAL MANAGEMENT LP
By: /s/ Samantha Nasello
Name:  Samantha Nasello
Title:  CCO
SCOPIA MANAGEMENT, INC.
By: /s/ Aaron Morse
Name:  Aaron Morse
Title:  Vice President
By: /s/ Matthew Sirovich
Name:  Matthew Sirovich
By: /s/ Jeremy Mindich
Name:  Jeremy Mindich

Note.  Schedules filed in paper format shall include
a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties for whom copies are
to be sent.

Attention.  Intentional misstatements or omissions of
fact constitute Federal criminal violations (see 18 U.S.C. 1001).

Follow Gw Pharmaceuticals Plc (NASDAQ:GWPH)

Page 11 of 12